Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Industry Insights Seminar Series is hosted by the Business Partnerships Office

  • 12.00 -1.00 pm 
  • In person and via Zoom
  • In person at Institute of Developmental & Regenerative Medicine (IDRM), Old Road Campus, Headington, OX3 7TY
  • Networking & 1:1 meeting opportunities

Selected industry speakers provide seminars that are scientific in nature, across a range of medical or health topics.  Speakers are encouraged to bring along colleagues providing the opportunity for Oxford scientists to attend a scientific seminar of interest and also to network with industry scientists. One to one meetings can be facilitated upon request.  Seminars are suitable for all scientists with some knowledge or interest in each topic area, from PhD students to PIs.  Although mostly aimed at an academic audience, those located in the BioEscalator and Wood Centre, as well as local spinouts, are welcome to attend. 

Please contact Sheena Lee if you have any questions or have an industry partner you would like to invite to speak

2nd May: Precision proteomics broadens MultiOmics repertoire and enables biomarker discovery

Presenter: Dr Sarantis Chlamydas – Scientific Affairs Director for MultiOmics 

Company Olink

Description:  Olink Proteomics is a Swedish company with strong global presence, that enables high-plex protein biomarker discovery and development. Olink’s platform currently has the ability to robustly measure ~5,400 analytes. It’s been used in different settings due to its scalability and actionability such as in the elucidation of pathways and mechanisms of drug action, as a screening tools for identifying signatures/biomarkers with a prognostic/predictive significance as well as to safety and toxicity studies, drug target selection and differentiation. Due to the fact that the protein library, which continuously expands, covers all major biological pathways the applications are in numerous disease areas, such as, Cardiology, Diabetes Immuno-oncology and Neurology.

In this scientific seminar we will go through a series of case studies elucidating the power of our capabilities.

As a general overview:

  • How Olink technology enables biomarker identification, precision medicine and multiOmics approaches.
  • Examples of Olink technology applied in specific human disease areas.

Register: by clicking on the following link: Registration

6th June 2024: The transformative role of Somascan for protein biomarker discovery, validation and translation

Presenter: Dr Shea Hamilton (Research Fellow Infectious Disease, Imperial College)

Company: Somalogic

Description: Somalogic aims to transform research and healthcare with industry-leading proteomics. Their pioneering platform provides more coverage of the proteome than any other than any other technology.

Register: by clicking on the following link: Registration

 

 

On this page